India Ratings affirmed Glenmark Pharmaceuticals' Bank Loans with an IND AA+ stable outlook

Glenmark Pharmaceuticals Ltd announced credit rating actions from India Ratings and Research, which affirmed its IND AA+ rating with a stable outlook for its Bank Loans and also rated Additional Loans, though specific details regarding the Additional Loans rating were not provided. India Ratings, alongside India Ratings and Research, provided limited information regarding Glenmark’s instruments, with no rating information found for any other instruments; the rating rationale from India Ratings and Research is enclosed, and no enhancements, assignments, or withdrawals were noted across any of the reviewed instruments.